Background: The therapeutic value of mesenchymal stem cells (MSCs) in tissue engineering and regenerative medicine is attributable in part to paracrine pathways triggered by several secreted factors secreted into culture media. The secreted factor here is known as the conditioned medium (CM) or secretome. Objectives: This review is aimed to investigate and summarise the in-vitro, pre-clinical in-vivo studies regarding the role of CM-MSC in bone regeneration from 2007 until 2018 Data Sources: A systematic literature search on PubMed, MEDLINE, OVID, Scopus and Cochrane library was carried out by using search terms: Secretome, conditioned medium, mesenchymal stem cell, bone healing, osteogenic, osteogenesis.
INTRODUCTION
Bone healing is a multistage repair process that involves complex yet well-orchestrated process which depends on numerous factors including cellular, molecular, and mechanical events. The skeleton differs from other adult tissues that generate scar tissue at the site of an injury; it heals by forming new bone that is indistinguishable from an uninjured bone. However, bone healing remains challenging in musculoskeletal care [1] . Limitations with the use of autograft and allograft have led numerous studies into the exciting and evolving field of mesenchymal stem cells (MSCs) tissue engineering [2] .
However, several issues with stem cells remain to be addressed, including tumorigenesis, [3] poor survival of implanted cells [4, 5] , transmission of infectious disease, and hostversus-graft disease. Besides, stem cell culture procedure is limited by a number of technical and ethical issues such as complicated safety and quality management issues with cell handling with the need of higher capital investment. According to recent literature from 2007-2018, the therapeutic value of mesenchymal stem cells in tissue engineering and regenerative medicine is attributable in part to paracrine pathways [6, 7] triggered by several secreted factors secreted into culture media. The secreted factor here is known as the conditioned medium (CM) or secretome.
The secretome of MSCs is special, as a nondonor-specific and can be lyophilised, enabling more practical storage conditions [6] . These findings reinforce many researchers to look further into this molecule regarding their contents in the bone healing capability and to solve the existing problems with cell handling described earlier. This systematic review aims to elaborate studies that have been conducted to evaluate the osteogenic potency or the bone regeneration capability of secretome/CM-MSC.
METHODS
A systematic literature search using PubMed, Medline, OVID, Scopus and Cochrane library was carried out. The following keywords and search terms were used in the following order in each of the databases using a snowballing technique to cite the relevant articles: Secretome, conditioned medium, mesenchymal stem cells, osteogenic. The search was performed by an initial reviewer and subsequently checked by a second reviewer. Discussion resolved any disputes about whether an article met the inclusion criteria. The following inclusion criteria were applied:
1. Studies/reviews describing the potency of secretome or conditioned-medium mesenchymal stem cells in the acceleration of osteogenesis or chondrogenesis 2. Studies that involve osteogenicity in the maxillofacial surgery 3. Studies involving the acceleration of bone healing in the hypoxic condition 4. Studies published within 10 years prior 5. Studies in the English language 6. In-vitro and in-vivo studies Fig. 1 . 
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RESULTS
The role of CM-MSC in the in-vitro studies is summarised in Table 1 . There was one study evaluating the role of MSC-CM in vitro. In 2014, Lee et al. hypothesised that embroid bodies (EBs) that were composed of either human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) with a hMSC-CM may stimulate mesodermal lineage induction. Through this induction, differentiation toward the osteogenic and chondrogenic lineage proven by quantitative reverse-transcription-polymerase chain reaction (qRT-PCR), cytochemistry, immunocytochemistry, and flow cytometry, was promoted [7] .
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Meanwhile, role of CM-MSC in animal studies is summarised in Table 2 . 9 studies were evaluating various pathways of CM-MSC in accelerating the bone regeneration. The most critical factor for fracture union is the blood supply to the fracture site. There were two studies which evaluated the importance of angiogenesis capability hence the vascular endothelial growth factor (VEGF) in CM-MSC during acceleration of bone regeneration. In 2017, Katagiri et al. [8] . examined the value VEGF in the CM-MSC to accelerate the bone healing by comparing four groups of treatment consisting of MSC-CM, MSC-CM + anti-VEGF antibody, phosphate buffer saline (PBS), and control group with an unfilled defect. His research besides has successfully quantified the amount of IGF-1, VEGF, and TGF-β1 using ELISA, using a reconstruction computed tomography (CT) evaluation also proven a significant increase of new bone formation in the MSC-CM group compared to other groups which were verified by histological and immunohistochemistry (IHC) analysis. Meanwhile, Wang et al [9] in 2011 investigated the effects of hypoxic MSC-CM on tissue ingrowth, angiogenesis, and bone repair in the diabetic Sprague Dawley (SD) rats and proved that MSC-CM prepared under hypoxic conditions showed positive effects on angiogenesis following subcutaneous implantation and facilitated healing of segmental bone defect in a diabetic rat model. When normal bone healing process is insufficient, supportive therapeutic strategies can be used to stimulate and augment bone regeneration (Walsh et al., 2008) [10] . Sun et al., 2012 [11] has reported that to enhance the effect of MSC in proliferation and differentiation of osteoblasts, a sensitive microenvironment can be formed. Chang et al. in 2015 proved that CMrMSC collected under hypoxic condition could effectively influence bone regeneration through enhanced migration and adhesion of endogenous MSC in the SD rats with calvaria bone defect [12] .
There were four studies including the works of Feng in 2012 [13] , Katagiri 2013 [14] , Linero 2014 [15] , and Brudette 2017 [6] , which evaluated the efficacy of CM-MSC from many sources (murine, human, human, human and amnion respectively) in rats' (except for Linero in rabbit) calvaria and mandible. All studies were evaluated using conventional radiograph, reconstruction CT scan, histological analysis, IHC, western blot, and RT-PCR. All studies have shown positive results where secretome enhanced the proliferation and migration of MSC osteogenic differentiation significantly.
A novel route of CM-MSC administration had been introduced by Ando et al in 2014 [16] who administered serum-free CM-hMSC locally in high-speed distraction osteogenesis (DO) in a mouse model. The CM-MSC was proved to promoted the recruitment of murine CMSCs and of endothelial cells/endothelial progenitor cells (EC/EPCs), and the establishment of a neoangiogenic network hence accelerating neo callus formation in the DO gap.
Implant fixation is commonly used in nonunion or bone defect cases, and its integration with CM-MSC should be understood. One of the material commonly used is titanium (Ti). In 2013, Tsuchiya investigated methods to enhance the stability of Ti implants using CM-BMSCs. Rat BMSC-CM was successfully immobilised on Ti implants [17] . The immobilised CM contained about 2000 proteins, including collagen type I, bone sialoprotein, fibronectin, and VEGF, which are essential for new bone formation. CM promoted cell adhesion and osteocalcin gene expression of rat BMSCs. The labeled CM remained associated with the Ti implant at 1, 7, 14, and 28 days postimplantation. Compared to controls, the removal torque value and BIC of Ti implants with immobilised CM were higher than on days 1, 7, and 14 after implantation.
DISCUSSIONS
It is clear that the included studies have demonstrated that the therapeutic effects of transplanted stem cells are considered to be effective for tissue regeneration. In addition, they play an essential role as cellular modulators, apart from their multi-potent differentiation ability [18] [19] [20] . Stem cells, including MSCs, are attracted to damaged tissue site where they produce the secretome that enhances angiogenesis, reduces inflammation, promotes tissue repair, and inhibits fibrosis and cell apoptosis [21] [22] [23] . The application of cell-free secretome may avoid the limitations associated with cell therapy, including higher costs for cell preparation, longer waiting time, and immune incompatibility [24, 25] . Although it has been proven that the effect of MSC is mainly due to its paracrine effect, reviews regarding the osteogenic potency of this paracrine effect concerning bone regeneration promotion are scarce. The ALP, OCN, and Runx2 genes expression levels were significantly upregulated in rMSCs cultured in MSC-CM compared to rMSCs cultured in control medium
After two weeks, the mean area of newly regenerated bone in the MSC-CM defects was significantly increased compared to that of the unfilled defects and the PBS-treated sites (81.50% ± 2.7%, 8.63% ± 1.78%, and 60.63% ± 5.8%, respectively). After four weeks, the defect areas were almost completely filled by newly formed bone in the MSC-CM and PBS groups (93.07% ± 6.6% and 84.04% ± 4.9%, respectively).
Study Secretome source Trial Evaluation Results
At 2 weeks, the bone defect in the MSC-CM group was almost covered with newly regenerated bone. Whereas in the PBS group, the defect was covered with a large amount of connective tissue. At 4 weeks, newly regenerated bone was partially noticeable within the defect of the PBS group. However, in the MSC-CM group, the defect was almost completely replaced by mature bone tissue Linero, 2014 15 PLoS ONE hAdMSC Aim: to evaluate the ability of hAd-MSC and their CM by radiographic, morphometric and histological analysis, and to repair surgical bone lesions using an in vivo model (rabbit mandibles) delivered with human blood plasma hydrogels (HBPH)
Group I: 12 rabbits with HBPHs + Ad-MSC + HBPHs w/o cells on contralateral side (control) Each 4 animal sacrificed at 15, 30, 45 days after surgery Group II: 4 rabbits with HBPHs + Ad-MSC both sides and sacrificed 3, 6, 9, 12 days after treatment Group III: 3 rabbits with a hydrogel containing CM-1 on one side and CM-2 on contralateral side; sacrificed 45 days after surgery.
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Ad-MSC enhances bone regeneration process more through paracrine mechanism (conditioned medium). When paracrine factors collected and applied as CM are used instead of Ad-MSC itself which is undetected after 12 days of implantation, the amount and quality of regenerated bone is similar. Compared to controls, removal torque value and BIC of Ti implants with immobilized CM were higher on days 1, 7, and 14 post-implantation.
During an initial stage, immobilized CM components on the surface of Ti implants promoted integration into bone.
We have observed that all included studies in this review revealed that the CM-MSC significantly enhances the bone regeneration compared to normal medium [6, 7, 9, [12] [13] [14] [15] [16] [17] . The secretome was proven to be superior compared to MSC alone [14] . The transplanted MSC have poor differentiation and survival of engrafted stem cells suggesting that the regenerative properties of these cells are exerted primarily through paracrine mechanisms. However, there was a study stating that no superiority between CM-MSC and MSC in terms of osteogenic potency was found [15] . Ad-MSC improves bone regeneration process, and that the amount and quality of regenerated bone is similar when paracrine factors collected and applied as CM are used instead of Ad-MSC [15] .
The CM-MSC effect was also proven to be increased under stress condition, including hypoxia [9, 13] . MSCs express significantly higher levels of several arteriogenic cytokines when subjected to hypoxic stress [26] . When they are deprived of serum, starvation stress induces them to secrete angiogenic factors [27] . In general, severe stress causes cells to activate survival pathways and secrete factors to counteract toxic conditions. 27 Therefore, severe stress conditions may significantly increase the therapeutic efficiency of factors harvested in the MSC-CM.
The most critical factor for new bone formation is adequate blood supply [28] ; impairment of angiogenesis at the fracture site usually results in non-union or delayed union [29] . MSCs also have been shown to secrete cytokines and growth factors that can inhibit hypoxia-induced endothelial apoptosis and promote angiogenesis [30] . Several studies have determined that CM-MSC, especially that prepared under hypoxic conditions, contains a higher amount of angiogenic factors [30, 31] . Wang et al., [25] have proved that MSC-CM has shown significantly higher levels of angiogenesis factors (VEGF and IL-6) and that MSC-CM delivered in gelatin sponges stimulates angiogenesis and promotes fracture healing in a diabetic rat model and may be an alternative strategy for treating fracture non-union in patients with diabetes.
There was one study by Ando et al., advocating a novel administration technique of MSC-CM in a DO model. The study demonstrated that when locally administered into the H-DO gap, MSC-CM promoted new bone callus formation at the distal end of the gap by accelerating the recruitment of endogenous mBMSCs and EC/EPCs. He also elaborated the ten tissue-regenerating trophic factors that participated in the recruitment of endogenous BMSCs and EC/EPCs as well as in osteoblast differentiation, angiogenesis, cell proliferation, and inflammation suppression. This finding offers an opportunity for newer less invasive and effective method of bone healing treatment with MSC-CM.
Mechanical stabilisation is the key factor in the diamond concept of bone healing accompanied with osteoprogenitor cells, osteoinductive proteins, and osteoconductive scaffolds. [32, 33] Upon the usage in patients in clinical settings, a combination of MSC-CM with fixation is crucial. There was one study by Tsuchiya that proved that immobilised CM components on the surface of Ti implants promoted integration into bone during an early stage [17] .
Secretome-based approaches using CM may present osteogenic potential advantages over living cells regarding manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biological therapeutic agent [34] [35] [36] [37] [38] [39] [40] [41] .
Although the use of CM is generally safe from ethical issues, inflammatory risk, tumorigenesis complication, and even host-versus-graft disease, studies that evaluate the risk, harm, safety of CM application should be performed, and comparison potency of MSC-CM and MSC are needed [42] [43] [44] [45] [46] [47] [48] [49] [50] .
Our review also found the diverse source of MSC-CM used from murine, human, human adipose, human bone marrow, and amnion. However, there has been no study comparing the osteogenic potency of each of them. Further research might also evaluate the comparison of dosages related effect in the MSC-CM application to obtain the optimum dosage with the least side effects in the clinical setting.
Finally, more extensive trials on animal models with more extended observation period are required to answer these questions above before conduction clinical trials on human subjects.
CONCLUSION
All of the included in-vitro studies and in-vivo studies from 2007-2018 have shown a promoting effect of bone regeneration at various stages. Although there is no clinical study regarding the use of CM-MSC in the human bone regeneration to this date, transplantation of secretome has shown a promising result in the acceleration of bone healing process.
